A Study of the Drug Casopitant for the Prevention of Nausea Caused By Cisplatin-Based Highly Emetogenic Chemotherapy

Clinical trial NCT00431236 · COMPLETED

Trial details

NCT number: NCT00431236
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Nausea and Vomiting, Chemotherapy-Induced

Start date: 2006-11-06
Primary completion: 2007-10-09
Enrollment: 810

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.